Bierbaum W, Bremer K, Firusian N, Higi M, Niederle N, Scheulen M E, Schmidt C G, Seeber S
Dtsch Med Wochenschr. 1981 Sep 11;106(37):1181-5. doi: 10.1055/s-2008-1070478.
43 patients with metastasizing sarcomas were treated with a combination of either vincristin, adriamycin and cis-platinum (n = 21) or ifosfamide and cis-platinum at three weeks' intervals in each case. Ten patients responded to the first combination and nine to the second combination with objective tumor regression. Particularly the latter result is remarkable since 16 of the 22 patients had already been pretreated with combinations containing adriamycin. Obviously the combination of ifosfamide and cis-platinum is a promising alternative in metastasizing sarcomas of the bones and soft tissue, especially if the CYVADIC combination--which is often regarded as standard treatment--remained unsuccessful. This has no bearing on additional surgical measures or on radiotherapy which may be necessary in some patients.
43例转移性肉瘤患者接受了长春新碱、阿霉素和顺铂联合治疗(n = 21),或异环磷酰胺和顺铂联合治疗,每种治疗方案均每三周进行一次。10例患者对第一种联合治疗有反应,9例患者对第二种联合治疗有反应,肿瘤客观缩小。尤其后一结果引人注目,因为22例患者中有16例此前已接受过含阿霉素的联合治疗。显然,异环磷酰胺和顺铂联合治疗对于骨与软组织转移性肉瘤是一种有前景的替代方案,特别是当常被视为标准治疗的CYVADIC联合治疗无效时。这与某些患者可能需要的额外手术措施或放疗无关。